{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:04Z","timestamp":1761630424160,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jinf.2005.11.017","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T07:29:52Z","timestamp":1158823792000},"page":"241-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Bloodstream infections in organ transplant recipients receiving alemtuzumab: No evidence of occurrence of organisms typically associated with profound T cell depletion"],"prefix":"10.1016","volume":"53","author":[{"given":"Fernanda P.","family":"Silveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amadeo","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun J.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"McCurry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem","family":"Abu-Elmagd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.11.017_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000128625.29654.EB","article-title":"The use of Campath-1H as induction therapy in renal transplantation: preliminary results","volume":"78","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.TP.0000116562.15920.43","article-title":"Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation","volume":"77","author":"Tzakis","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.transproceed.2004.01.106","article-title":"Three-year experience in clinical intestinal transplantation","volume":"36","author":"Masetti","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jinf.2005.11.017_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.TP.0000142674.78268.01","article-title":"Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus","volume":"78","author":"Marcos","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1399-3046.2003.00139.x","article-title":"Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients","volume":"8","author":"Knechtle","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jinf.2005.11.017_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.surg.2004.06.015","article-title":"Campath-1H in renal transplantation: The University of Wisconsin experience","volume":"136","author":"Knechtle","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.jinf.2005.11.017_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00007890-200209270-00034","article-title":"Treatment of refractory acute rejection in a lung transplant recipient with campath 1H","volume":"74","author":"Reams","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/146532401753174098","article-title":"The CD52 antigen and development of the CAMPATH antibodies","volume":"3","author":"Hale","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jinf.2005.11.017_bib9","first-page":"301","article-title":"Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients","volume":"101","author":"Calne","year":"2000","journal-title":"Nippon Geka Gakkai Zasshi"},{"key":"10.1016\/j.jinf.2005.11.017_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2005.11.017_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.TP.0000071362.99021.D9","article-title":"Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)","volume":"76","author":"Kirk","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib12","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.11.017_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/425002","article-title":"The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients","volume":"39","author":"Munoz-Price","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(05)80245-4","article-title":"Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis","volume":"18","author":"Paya","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2005.11.017_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005792-198803000-00006","article-title":"Infections after liver transplantation. An analysis of 101 consecutive cases","volume":"67","author":"Kusne","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2005.11.017_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2567.1996.d01-650.x","article-title":"Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H","volume":"88","author":"Brett","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.jinf.2005.11.017_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.leu.2403258","article-title":"Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia","volume":"18","author":"Lundin","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jinf.2005.11.017_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.leu.2403561","article-title":"Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia","volume":"19","author":"Laurenti","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jinf.2005.11.017_bib19","first-page":"142","article-title":"Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow","volume":"67","author":"Parreira","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2005.11.017_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1600-6143.2005.00879.x","article-title":"Campath-1H use in pediatric renal transplantation","volume":"5","author":"Bartosh","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2005.11.017_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jtcvs.2004.09.040","article-title":"Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy","volume":"130","author":"McCurry","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jinf.2005.11.017_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jinf.2005.11.017_bib23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/165.6.1082","article-title":"Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients","volume":"165","author":"Nightingale","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib25","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/315367","article-title":"A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy","volume":"181","author":"Archibald","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/165.3.553","article-title":"Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine","volume":"165","author":"Rodriguez-Barradas","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/167.1.49","article-title":"Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection","volume":"167","author":"Janoff","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/162.5.1012","article-title":"The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents","volume":"162","author":"Redd","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/infdis\/156.6.998","article-title":"Incidence of salmonellosis in patients with AIDS","volume":"156","author":"Celum","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/24.1.1","article-title":"Listeriosis","volume":"24","author":"Lorber","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.11.017_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0002-9343(87)90150-1","article-title":"Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex","volume":"82","author":"Witt","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2005.11.017_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archinte.1986.00360130139019","article-title":"Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome","volume":"146","author":"Fischl","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2005.11.017_bib33","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/archinte.1985.00360110038010","article-title":"Salmonella bacteremia associated with the acquired immunodeficiency syndrome (AIDS)","volume":"145","author":"Nadelman","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2005.11.017_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2005.11.017_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","article-title":"Invasive aspergillosis in transplant recipients","volume":"78","author":"Paterson","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2005.11.017_bib36","first-page":"54","article-title":"Predicting bacteremia and bacteremic mortality in liver transplant recipients","volume":"6","author":"Singh","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jinf.2005.11.017_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-0012.1997.tb00819.x","article-title":"Bloodstream infections in liver transplant recipients receiving tacrolimus","volume":"11","author":"Singh","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jinf.2005.11.017_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0196-6553(05)80197-X","article-title":"Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes","volume":"20","author":"Wagener","year":"1992","journal-title":"Am J Infect Control"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305003816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305003816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:30:12Z","timestamp":1758987012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305003816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0163445305003816"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.11.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bloodstream infections in organ transplant recipients receiving alemtuzumab: No evidence of occurrence of organisms typically associated with profound T cell depletion","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}